Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Dresden GAS Study Group - (Author)
  • Susann Rößler - , Institute of Medical Microbiology and Virology (Author)
  • Sébastien Boutin - , Airway Research Center North (ARCN) - DZL Borstel, University Hospital Schleswig-Holstein - Campus Lübeck, German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems (Author)
  • Reinhard Berner - , Department of Paediatrics, Medical Faculty Carl Gustav Carus (Author)
  • Markos K Tomidis Chatzimanouil - , Department of Paediatrics, Medical Faculty Carl Gustav Carus (Author)
  • Meriem Belheouane - , Research Center Borstel - Leibniz Lung Center, German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems (Author)
  • Jan Rupp - , University Hospital Schleswig-Holstein - Campus Lübeck, German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems (Author)
  • Matthias Merker - , Research Center Borstel - Leibniz Lung Center, German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems (Author)
  • Nicole Töpfner - , Department of Paediatrics, Medical Faculty Carl Gustav Carus (Author)
  • Dennis Nurjadi - , German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, University Hospital Schleswig-Holstein - Campus Lübeck (Author)

Abstract

BACKGROUND: Several European countries have reported a rise in invasive Group A Streptococcus (GAS) infections, particularly linked to the toxigenic emm1 sublineage M1UK. In Germany, historical molecular data are limited due to the absence of systematic molecular surveillance.

METHODS: We performed whole-genome sequencing (WGS) on 189 invasive Streptococcus pyogenes isolates collected between January 1, 2015, and May 31, 2023, at University Medical Center Carl Gustav Carus, TU Dresden. Clinical data were extracted from patient records. M1UK sublineage identification was based on 27 characteristic single nucleotide polymorphisms (SNPs). A Bayesian coalescent analysis estimated the evolutionary timescales of the M1UK clade in Germany.

RESULTS: The most common emm type was emm1 (34%, 64/189), followed by emm12, emm4, and emm89. Of the 64 emm1 isolates, 31 (48%) were M1UK. No significant associations were found between clinical outcomes and M1UK or M1global genotypes. Although a post-pandemic shift favouring M1UK was observed, our analysis indicates that M1UK had already been circulating in Germany by 2017. The estimated most recent common ancestor dates to 2012 (95% highest posterior density: 2009-2015), with a stable effective population size over time.

CONCLUSION: Our findings confirm the pre-pandemic circulation of M1UK in Germany. While the clinical impact of M1UK remains unclear, integrating clinical data with high-resolution molecular surveillance may improve early detection of emerging high-risk clones.

Details

Original languageEnglish
Article number2576587
Number of pages1
JournalEmerging microbes & infections
Volume14
Issue number1
Publication statusPublished - 14 Dec 2025
Peer-reviewedYes

External IDs

PubMedCentral PMC12584839
Scopus 105020771006
ORCID /0000-0003-3906-7782/work/198595086

Keywords

Keywords

  • Adolescent, Adult, Aged, Antigens, Bacterial/genetics, Bacterial Outer Membrane Proteins/genetics, Bayes Theorem, Carrier Proteins/genetics, Child, Child, Preschool, Female, Genotype, Germany/epidemiology, Humans, Infant, Male, Middle Aged, Phylogeny, Polymorphism, Single Nucleotide, Streptococcal Infections/epidemiology, Streptococcus pyogenes/genetics, Whole Genome Sequencing, Young Adult